Exosome microRNAs as liquid biopsies for the monitoring of prostate cancer

Neuroendocrine prostate cancer (NEPC) is a highly aggressive variant of prostate cancer.

Neuroendocrine prostate cancer (NEPC) is a highly aggressive variant of prostate cancer that emerges in response to hormone therapy. Dr Sharanjot Saini and her staff, from the Medical College of Georgia at Augusta University, USA, are studying exosomes – nano-sized vesicles that transfer lipids, proteins, or genetic information between cells. These could be used as a source of biomarkers to […]

Read More… from Exosome microRNAs as liquid biopsies for the monitoring of prostate cancer

New independent research clarifies risks associated with different MHT (HRT) treatments

Oestrogen levels fluctuate with age.

Menopausal hormone therapy (MHT) is used to ease severe symptoms associated with the menopause and can be administered in tablet, patch, gel, or implant form. However, previous research has suggested treatments may have serious side effects, including increased risks of developing blood clots, breast cancer, and dementia. Dr Yana Vinogradova of Nottingham University Medical School, UK, supported by UK researchers […]

Read More… from New independent research clarifies risks associated with different MHT (HRT) treatments